Q-linea AB (publ) 67,10
Q-linea AB (publ) engages in the development of instruments and consumables for infection diagnostics in Sweden. It offers inventive systems for in vitro diagnostics systems for infectious diseases. The company's lead product candidate is ASTar, an antibiotic susceptibility testing system used for positive blood cultures. It develops and delivers solutions for healthcare providers. Q-linea AB (publ) was incorporated in 2008 and is headquartered in Uppsala, Sweden. Læs mere
Kr. 1,9B Markedsværdi (Mcap)
Kr. 16,0M Omsætning
Medicinsk udstyr Industri
Sverige Handles på børsen
qlinea.com Hjemmeside
Sundhed Sektor